Moneycontrol PRO

you are here: HomeNewsBusinessStocksDipan Mehta cautious on midcap IT & pharma

SHOW NAMES

Trending Topics

business

Dipan Mehta cautious on midcap IT & pharma

Dipan Mehta, member at BSE & NSE has a cautious view on midcap IT and midcap pharma.

first published: Mar 16, 2015 01:54 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live
LIVE: RBI Governor Sanjay Malhotra Delivers Key Monetary Policy Statement | Interest Rates & Outlook
Nifty’s Move Hinges On RBI Rate Decision; HUL, ITC Hotels In Focus| Opening Bell Live
Nifty Sideways But Holds 26,000 Ahead Of MPC Rate Decision| IT & Realty Upbeat| Closing Bell Live

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347